Weihua Hu
- Molecular Biology
- Oncology top 10%
- Immunology top 10%
- Cancer Research top 10%
- Infectious Diseases top 10%
- Topics
- COVID-19 Clinical Research Studies (11 papers)Long-Term Effects of COVID-19 (8 papers)SARS-CoV-2 and COVID-19 Research (6 papers)
- Cited by
- Cancer ResearchOncologyImmunology
- Journals
- Clinical Infectious DiseasesBiochemical and Biophysical Research CommunicationsEnvironmental Pollution
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Weihua Hu
81 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 128
- Molecular Biology 419
- Oncology 353
- Immunology 260
- Cancer Research 228
- Infectious Diseases 220
Countries citing papers authored by Weihua Hu
This map shows the geographic impact of Weihua Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weihua Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weihua Hu more than expected).
Fields of papers citing papers by Weihua Hu
This network shows the impact of papers produced by Weihua Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weihua Hu. The network helps show where Weihua Hu may publish in the future.
Co-authorship network of co-authors of Weihua Hu
This figure shows the co-authorship network connecting the top 25 collaborators of Weihua Hu. A scholar is included among the top collaborators of Weihua Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weihua Hu. Weihua Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 5 | |
| 3 | 3 | |
| 4 | 7 | |
| 5 | 9 | |
| 6 | 4 | |
| 7 | 6 | |
| 8 | 8 | |
| 9 | 4 | |
| 10 | 10 | |
| 11 | 7 | |
| 12 | 16 | |
| 13 | 22 | |
| 14 | 7 | |
| 15 | 16 | |
| 16 | 4 | |
| 17 | 15 | |
| 18 | 15 | |
| 19 | 31 | |
| 20 | 15 |
About Weihua Hu
Weihua Hu is a scholar working on Modeling and Simulation, Infectious Diseases and Aquatic Science, having authored 85 papers that have together received 1.4k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (11 papers), Long-Term Effects of COVID-19 (8 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). The work is most often cited by research in Cancer Research (228 citations), Oncology (353 citations) and Immunology (260 citations). Weihua Hu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Fengjing Guo, Anmin Chen, Fengshu Zhao, Jun Dou, Kai Hu, Weikai Zhang, Lili Chu, Ning Gu, Yating Li and Yaping Ye. Their work appears in journals such as Clinical Infectious Diseases, Biochemical and Biophysical Research Communications and Environmental Pollution.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.